Filing Details
- Accession Number:
- 0001181431-11-009542
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-11 16:55:52
- Reporting Period:
- 2011-02-09
- Filing Date:
- 2011-02-11
- Accepted Time:
- 2011-02-11 16:55:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1311210 | Patrick Clarence Machado | C/O Medivation, Inc. 201 Spear Street, 3Rd Floor San Francisco CA 94105 | Chief Business Officer And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-02-09 | 2,800 | $15.55 | 101,061 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2011-02-10 | 7,000 | $16.53 | 94,061 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2011-02-10 | 7,000 | $17.58 | 87,061 | No | 4 | S | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 16,666 | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 Plan.
- The shares were sold at prices between $15.50 and $15.60. The reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices between $16.50 and $16.56. The reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices between $17.50 and $17.67. The reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.